Refine
Language
- English (12) (remove)
Is part of the Bibliography
- yes (12)
Keywords
- COVID-19 (4)
- machine learning (3)
- dialysis (2)
- digital health (2)
- prediction (2)
- AKI (1)
- EHR (1)
- Markov model (1)
- N-of-1 trial (1)
- PPMI (parkinson's progression markers initiative) (1)
- SCED (1)
- TRIPOD (1)
- acute renal failure (1)
- app (1)
- back pain (1)
- chronic dialysis (1)
- clinical (1)
- clinical nephrology (1)
- cohort (1)
- coronavirus 2019 (1)
- cost-effectiveness (1)
- cost-utility analysis (1)
- databases (1)
- digital health app (1)
- digital interventions (1)
- digital therapy (1)
- eHealth (1)
- electronic health record (1)
- electronic health records (1)
- end-stage kidney disease (1)
- epistasis (1)
- factual (1)
- feature selection (1)
- health apps (1)
- hospital (1)
- human immunodeficiency virus (1)
- informatics (1)
- information storage and (1)
- low back pain (1)
- mHealth (1)
- mobile application (1)
- mobile health (1)
- mortality (1)
- orthopedic; (1)
- pain management (1)
- parkinson's disease (1)
- performance (1)
- retrieval (1)
- severe acute respiratory (1)
- single-case experimental design (1)
- software/instrumentation (1)
- syndrome coronavirus 2 (1)
- web application (1)
- workflow (1)
Institute
- Hasso-Plattner-Institut für Digital Engineering gGmbH (12) (remove)
Background:
Early reports indicate that AKI is common among patients with coronavirus disease 2019 (COVID-19) and associatedwith worse outcomes. However, AKI among hospitalized patients with COVID19 in the United States is not well described.
Methods:
This retrospective, observational study involved a review of data from electronic health records of patients aged >= 18 years with laboratory-confirmed COVID-19 admitted to the Mount Sinai Health System from February 27 to May 30, 2020. We describe the frequency of AKI and dialysis requirement, AKI recovery, and adjusted odds ratios (aORs) with mortality.
Results:
Of 3993 hospitalized patients with COVID-19, AKI occurred in 1835 (46%) patients; 347 (19%) of the patientswith AKI required dialysis. The proportionswith stages 1, 2, or 3 AKIwere 39%, 19%, and 42%, respectively. A total of 976 (24%) patients were admitted to intensive care, and 745 (76%) experienced AKI. Of the 435 patients with AKI and urine studies, 84% had proteinuria, 81% had hematuria, and 60% had leukocyturia. Independent predictors of severe AKI were CKD, men, and higher serum potassium at admission. In-hospital mortality was 50% among patients with AKI versus 8% among those without AKI (aOR, 9.2; 95% confidence interval, 7.5 to 11.3). Of survivors with AKI who were discharged, 35% had not recovered to baseline kidney function by the time of discharge. An additional 28 of 77 (36%) patients who had not recovered kidney function at discharge did so on posthospital follow-up.
Conclusions:
AKI is common among patients hospitalized with COVID-19 and is associated with high mortality. Of all patients with AKI, only 30% survived with recovery of kidney function by the time of discharge.